Lataa...

Prediction of tamoxifen outcome by genetic variation of CYP2D6 in post-menopausal women with early breast cancer

The question of whether genetic polymorphisms of CYP2D6 can affect treatment outcome in patients with early post-menopausal oestrogen receptor (ER)-positive breast cancer has been a matter of debate over the past few years. In this article we revisit the hypothesis of CYP2D6 being a potential tamoxi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Brauch, Hiltrud, Schwab, Matthias
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Blackwell Publishing Ltd 2014
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3971985/
https://ncbi.nlm.nih.gov/pubmed/24033728
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12229
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!